MoneyWorks4Me

Sandu Pharmaceuticals informs about issuance of duplicate share certificate

29 Jul 2023 Evaluate

Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, Sandu Pharmaceuticals has informed that Link in time India, the Registrar and Share Transfer Agent (RTA) of the Company has stopped Transfer on receipt of the request for Duplicate issue of Shares for Shareholder, Jyoti Shah (Folio No: J02782), further details are enclosed.

The above information is a part of company’s filings submitted to BSE. 


Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..